A study in Gastrointestinal Endoscopy is the first case series to test the benefits and safety of provocative testing combined with endoscopy.
GI & Endoscopy
Philip M. Ginsburg, MD, is a gastroenterologist at Hamden's Gastroenterology Center of Connecticut.
Austin, Texas-based XBiotech has entered a research collaboration with Fabio Cominelli, MD, PhD.
Dublin, Ireland-based Allergan has partnered with the world champion paratriathlete Amy Dixon.
Samuel C. Somers, MD, is a gastroenterologist at Concord-based GI Associates of New Hampshire.
Advertisement
Here are five updates on gastroenterology and endoscopy companies.
A study in OncologyNurseAdvisor clarified the role of a nurse navigator during a colonoscopy screening.
Boston-based NinePoint Medical is benefiting from CMS' updated final fee schedule with its NvisionVLE Imaging System meeting criteria for a substantial increase in reimbursement.
New Haven, Conn.-based Alexion Pharmaceuticals has released data from studies related to the Phase 3 ARISE trial of Kanuma. Kanuma, or sebelipase alfa, is a drug treatment for lysosomal acid lipase deficiency.
New York-based Intercept Pharmaceuticals has released data from three studies related to the Phase 3 POISE trial of Ocaliva. The POISE trial tested daily Ocaliva treatment in patients with primary biliary cholangitis with an inadequate therapeutic response to ursodeoxycholic acid.